imipenem, anhydrous has been researched along with Primary Peritonitis in 70 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 5 (7.14) | 18.7374 |
1990's | 34 (48.57) | 18.2507 |
2000's | 14 (20.00) | 29.6817 |
2010's | 15 (21.43) | 24.3611 |
2020's | 2 (2.86) | 2.80 |
Authors | Studies |
---|---|
Al Qarni, A; Arapis, K; Augustin, P; Grall, N; Montravers, P; Parenti Ribeiro, L; Tanaka, S; Tran-Dinh, A | 1 |
Canovas, J; Chau, F; Fantin, B; Le Monnier, A; Lefort, A; Petitjean, G | 1 |
Gong, N; Jiang, J; Yang, L; Zhou, H | 1 |
Fernández, C; Losa, C; Martínez, NM; Medina, MJ; Sáez-Nieto, JA; Tena, D | 1 |
Belghiti, J; Bert, F; Dondero, F; Durand, F; Larroque, B; Moreau, R; Nicolas-Chanoine, MH; Paugam-Burtz, C | 1 |
Bhadoria, AS; Jindal, A; Kumar, M; Maiwall, R; Sarin, SK | 1 |
Gong, R; Huang, X; Li, C; Liu, J; Liu, Y; Xu, H | 1 |
Choe, KW; Jeon, JH; Kim, HB; Kim, NJ; Lee, HS; Oh, MD; Park, SW; Park, WB; Song, KH | 1 |
Cavallo, JD; Chomarat, M; Dubreuil, L; Joly-Guillou, ML; Kempf, M; Maugein, J; Muller-Serieys, C; Roussel-Delvallez, M | 1 |
Couet, W; Dahyot-Fizelier, C; Laksiri, L; Lefeuvre, S; Marchand, S; Mimoz, O; Sawchuk, RJ | 1 |
Bi, J; Chen, X; Chen, Z; Cooper, A; Leng, X; Li, R; Liu, D; Ma, X; Maroko, R; Quan, Z; Wei, J; Wu, J; Wu, Z; Yan, L; Yu, Y; Zhang, Y | 1 |
Ariza, J; Cabellos, C; Domínguez, MA; Fernández, R; Gudiol, F; Pachón-Ibáñez, ME; Ribes, S; Tubau, F | 2 |
Arias Rodríguez, M; Palomar Fontanet, R; Quintela Obregón, E; Rodrigo Calabia, E; Salas, C | 1 |
Conejo, MC; Docobo-Pérez, F; García, I; López-Rojas, R; Pachón, J; Pachón-Ibáñez, ME; Pascual, A; Pichardo, C; Rodríguez, JM; Velasco, C | 1 |
Higashi, M; Iwasaka, T; Kakimoto, S; Kido, E; Morimoto, S; Morita, T; Someya, K; Sumitani, N; Suzuki, K; Takagishi, H; Yasui, A | 1 |
Couet, W; Grégoire, N; Marliat, M; Mimoz, O; Nordmann, P; Poirel, L | 1 |
Chen, CC; Cheng, KC; Chiang, SR; Chiu, YH; Chuang, YC; Ko, WC; Ku, YH; Tang, HJ; Zhang, CC | 1 |
Cirioni, O; Ghiselli, R; Giacometti, A; Mocchegiani, F; Saba, V; Scalise, G; Viticchi, C | 1 |
Genné, D; Indino, P; Jaquet, A; Menetrey, A; Sénéchaud, C; Siegrist, HH | 1 |
Jones, DP; Kink, RJ; Lau, KK | 1 |
Doline, C; Kobrin, S; Lipschutz, JH; Nachamkin, I; Ruhe, J; Snyder, RW; Wasserstein, A | 1 |
Kotapati, S; Kuti, JL; Nicolau, DP | 1 |
Babinchak, T; Campos, M; Ellis-Grosse, EJ; Loh, E; Oliva, ME; Pasternak, J; Rekha, A; Rose, GM; Yellin, A | 1 |
Enoh, VT; Fairchild, CD; Lin, CY; Sherwood, ER; Varma, TK | 1 |
Couet, W; Lamarche, I; Lefeuvre, S; Marchand, S; Mimoz, O | 1 |
Barra, D; Bozzi, A; Cirioni, O; Di Giulio, A; Ghiselli, R; Giacometti, A; Luzi, C; Mangoni, ML; Mocchegiani, F; Orlando, F; Rinaldi, AC; Saba, V; Scalise, G; Silvestri, C | 1 |
Bonello, M; Dell'Aquila, R; Loreto, PD; Nalesso, F; Rodighiero, MP; Ronco, C; Spanò, E | 1 |
Cengiz, CK | 1 |
Johnson, SB; Orrico, RP; Suding, PN; Wilson, SE | 1 |
Anwar, N; Gokal, R; Merchant, M; Tooth, A; Uttley, L; Were, T | 1 |
Giercksky, KE; Lundblad, R | 1 |
De Vecchi, AF | 1 |
Cheng, AB; Lai, KN; Leung, CB; Li, PK; Lui, SF; Wong, KC | 1 |
Baumgartner, JD; Chopart, P; Cometta, A; Eggimann, P; Herter, C; Huber, O; Lew, D; Pittet, D; Schaad, U; Zimmerli, W | 1 |
Andremont, A; Carbon, C; Massias, L; Montravers, P | 1 |
Akli, J; Fichaux, A | 1 |
Levy, E; Levy, P | 1 |
Carles, J; Janvier, G | 1 |
Chloroyiannis, J; Giamarellou, H; Kanellakopoulou, K; Papadothomakos, P; Sfikakis, P; Theakou, R; Tsipras, H | 1 |
Colardyn, F; Faulkner, KL | 1 |
Bohnen, J; Christou, NV; Potvin, M; Rotstein, O; Turgeon, P; Wassef, R | 1 |
Barie, PS; Baumgartner, TF; Dellinger, EP; Rotstein, OD; Solomkin, JS; Vogel, SB; Yang, JY | 1 |
Garnache, F; Goffinet, P; Simon, M | 1 |
Faulkner, K; Wilson, SE | 1 |
Campise, M | 1 |
Ambrosetti, P; Aymon, D; Bille, J; Chiolero, R; Cometta, A; Glauser, MP; Harbarth, S; Huber, O; Jaccard, C; Lew, D; Praz, G; Ricou, B; Romand, J; Schneider, R; Troillet, N; Zanetti, G | 1 |
Gaus, W; Kujath, P; Lünstedt, B; Rodloff, AC | 1 |
Crespo, M; Marcén, R; Ortuño, J; Rivera, M; Teruel, JL | 1 |
Chautemps, R; Ganeo, M; Glauser, M; Harbarth, SJ; Lange, J; Lew, D; Morel, P; Mosimann, F; Trampuz, A; Zanetti, G; Zimmerli, W | 1 |
Hogaboam, CM; Kunkel, SL; Lukacs, NW; Steinhauser, ML; Strieter, RM | 1 |
Bleichrodt, RP; Kooi, K; Rosman, C; Westerveld, GJ | 1 |
Briskin, BS; Khachatrian, NN; Kuznetsov, EV; Nekrasova, NI; Sosnovikova, OG; Suplotova, AA | 1 |
Atkinson, AM; Teale, DM | 1 |
Anwar, N; Gokal, R; Merchant, MR; Tooth, JA; Uttley, L; Were, A | 1 |
Claesson, G; Eriksson, M; Rogers, JD | 1 |
Auvergnat, JC; Dabernat, H; Froidefond, S; Lemozy, J; Marchou, B; Saivin, S | 1 |
Cruz, C; del Busto, R; Faber, MD; Mezger, E | 1 |
Geary, I; Spencer, RC; Wilcox, MH | 1 |
Fuchimoto, S; Hamada, F; Kimura, H; Kitagawa, T; Konaga, E; Nishiyama, Y; Ogawa, K; Orita, K; Takeuchi, H; Tokuda, N | 1 |
Canteras, M; Gómez, J; Martín-Luengo, F; Ros, J; Ruiz, J; Valdés, M | 1 |
Cabuy, A; Daelemans, R; Lins, RL; Van den Eden, EJ; Verhaegen, J | 1 |
Busuttil, RW; Christou, NV; Dellinger, EP; Solomkin, JS | 1 |
Cevallos, R; Denis, F; Mounier, M; Pezé, P | 1 |
Johnson, E; Kennedy, RH; Leaper, DJ; Roberts, N; Sutton, A | 1 |
Avery, D; Kennedy, R; Leaper, D; Leow, C; Thomas, W | 1 |
Iida, S; Kohara, T; Matsui, Y; Noda, M; Ooiwa, K | 1 |
Amgwerd, R; Gonzenbach, HR; Simmen, HP | 1 |
Aebert, H; Bunzendahl, H; Hünefeld, G; Weissbrodt, H | 1 |
24 trial(s) available for imipenem, anhydrous and Primary Peritonitis
Article | Year |
---|---|
A randomized open label study of 'imipenem vs. cefepime' in spontaneous bacterial peritonitis.
Topics: Adult; Anti-Bacterial Agents; Ascitic Fluid; Bacterial Infections; Cefepime; Cephalosporins; Cross Infection; Drug Resistance, Multiple; Drug Therapy, Combination; Female; Humans; Imipenem; India; Liver Cirrhosis; Male; Middle Aged; Paracentesis; Peritonitis; Risk Factors; Severity of Illness Index; Survival Analysis; Time Factors | 2016 |
Efficacy and safety of tigecycline monotherapy vs. imipenem/cilastatin in Chinese patients with complicated intra-abdominal infections: a randomized controlled trial.
Topics: Adult; Aged; Anti-Bacterial Agents; Asian People; Bacterial Infections; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Female; Humans; Imipenem; Male; Middle Aged; Minocycline; Peritonitis; Tigecycline; Treatment Outcome | 2010 |
A multicenter trial of the efficacy and safety of tigecycline versus imipenem/cilastatin in patients with complicated intra-abdominal infections [Study ID Numbers: 3074A1-301-WW; ClinicalTrials.gov Identifier: NCT00081744].
Topics: Abdomen; Adult; Anti-Bacterial Agents; Appendicitis; Bacterial Infections; Cholecystitis; Cilastatin; Cilastatin, Imipenem Drug Combination; Diverticulitis; Double-Blind Method; Drug Combinations; Female; Humans; Imipenem; Intestinal Perforation; Male; Middle Aged; Minocycline; Peptic Ulcer Perforation; Peritonitis; Tigecycline | 2005 |
Concordance of interrater assessments of surgical methods to achieve source control of intra-abdominal infections.
Topics: Abdominal Abscess; Abdominal Cavity; Aged; Anti-Bacterial Agents; Appendicitis; Cholecystitis; Decision Making; Digestive System Diseases; Diverticulitis; Double-Blind Method; Female; Humans; Imipenem; Intestinal Perforation; Male; Middle Aged; Minocycline; Peritonitis; Professional Practice; Tigecycline | 2008 |
A prospective, randomized study of the comparative safety and efficacy of intraperitoneal imipenem versus vancomycin and netilmicin in the treatment of peritonitis on CAPD.
Topics: Drug Therapy, Combination; Female; Humans; Imipenem; Male; Middle Aged; Netilmicin; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis; Prospective Studies; Vancomycin | 1995 |
Imipenem/cilastatin sodium in the treatment of continuous ambulatory peritoneal dialysis-associated peritonitis.
Topics: Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Administration Schedule; Drug Combinations; Drug Therapy, Combination; Humans; Imipenem; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis; Staphylococcal Infections; Time Factors | 1994 |
Prospective randomized comparison of imipenem monotherapy with imipenem plus netilmicin for treatment of severe infections in nonneutropenic patients.
Topics: Adult; Aged; Bacteremia; Bacterial Infections; Cross Infection; Drug Therapy, Combination; Female; Humans; Imipenem; Male; Middle Aged; Netilmicin; Peritonitis; Pneumonia; Prospective Studies | 1994 |
[Contribution of imipenem/cilastatin in the treatment of peritonitis: a comparative economic analysis in the case of France].
Topics: Anti-Bacterial Agents; Cilastatin; Drug Therapy, Combination; Female; France; Humans; Imipenem; Length of Stay; Male; Middle Aged; Peritonitis; Prospective Studies; Retrospective Studies | 1993 |
[Efficacy and tolerance of imipenem/cilastatin in the adjuvant treatment of surgery for peritonitis in patients over the age of 70 years].
Topics: Aged; Aged, 80 and over; Cilastatin; Drug Evaluation; Drug Therapy, Combination; Female; Humans; Imipenem; Male; Peritonitis; Prospective Studies | 1993 |
Meropenem versus imipenem/cilastatin in the treatment of intraabdominal infections requiring surgery.
Topics: Adult; Aged; Cilastatin; Drug Therapy, Combination; Female; Gastrointestinal Diseases; Humans; Imipenem; Male; Meropenem; Middle Aged; Peritonitis; Prospective Studies; Thienamycins; Treatment Outcome | 1993 |
Intravenous meropenem versus imipenem/cilastatin in the treatment of serious bacterial infections in hospitalized patients. Meropenem Serious Infection Study Group.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Bacterial Infections; Cilastatin; Drug Therapy, Combination; Female; Hospitals; Humans; Imipenem; Infusions, Intravenous; Injections, Intravenous; Male; Meropenem; Middle Aged; Peritonitis; Protease Inhibitors; Respiratory Tract Infections; Thienamycins; Time Factors; Treatment Outcome; Urinary Tract Infections | 1996 |
Management of intra-abdominal infections. The case for intraoperative cultures and comprehensive broad-spectrum antibiotic coverage. The Canadian Intra-abdominal Infection Study Group.
Topics: Abdomen; Antibiotic Prophylaxis; Bacteria; Bacterial Infections; Cause of Death; Cefoxitin; Cephamycins; Cilastatin; Double-Blind Method; Drainage; Drug Resistance, Microbial; Female; Humans; Imipenem; Injections, Intravenous; Intraoperative Care; Male; Middle Aged; Peritonitis; Prospective Studies; Protease Inhibitors; Thienamycins; Treatment Failure; Treatment Outcome | 1996 |
[Peritonitis: dual treatment strategy of operation and antibiotics].
Topics: Adult; Cilastatin; Cilastatin, Imipenem Drug Combination; Combined Modality Therapy; Cost-Benefit Analysis; Debridement; Drug Combinations; Drug Therapy, Combination; Humans; Imipenem; Microbial Sensitivity Tests; Peritonitis; Survival Rate; Treatment Outcome | 1997 |
A randomized, double-blind clinical trial comparing cefepime plus metronidazole with imipenem-cilastatin in the treatment of complicated intra-abdominal infections. Cefepime Intra-abdominal Infection Study Group.
Topics: Abdomen; Abdominal Abscess; Adult; Aged; Antitrichomonal Agents; Appendicitis; Cefepime; Cephalosporins; Cilastatin; Double-Blind Method; Drug Therapy, Combination; Female; Gastrointestinal Diseases; Humans; Imipenem; Infections; Male; Metronidazole; Middle Aged; Peritonitis; Treatment Outcome | 1997 |
Impact an anatomical site on bacteriological and clinical outcome in the management of intra-abdominal infections.
Topics: Adult; Aged; Anti-Bacterial Agents; Appendicitis; Bacterial Infections; Bacteriological Techniques; Cause of Death; Cilastatin; Clindamycin; Combined Modality Therapy; Drug Therapy, Combination; Female; Gastrointestinal Diseases; Humans; Imipenem; Male; Meropenem; Middle Aged; Peritonitis; Risk Factors; Survival Rate; Thienamycins; Tobramycin; Treatment Outcome | 1998 |
Prospective randomized comparison of imipenem-cilastatin and piperacillin-tazobactam in nosocomial pneumonia or peritonitis.
Topics: Acute Disease; Adult; Aged; Cilastatin; Cilastatin, Imipenem Drug Combination; Cross Infection; Drug Combinations; Drug Therapy, Combination; Female; Humans; Imipenem; Male; Middle Aged; Penicillanic Acid; Peritonitis; Piperacillin; Pneumonia; Prospective Studies; Pseudomonas Infections; Tazobactam | 1998 |
[Comparative study of the cost-effectiveness of initial therapy with imipenem/cilastatin in secondary peritonitis].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Cilastatin; Cost-Benefit Analysis; Drug Costs; Drug Therapy, Combination; Female; Humans; Imipenem; Male; Middle Aged; Peritonitis; Prospective Studies; Surgical Wound Infection | 1998 |
Meropenem (1.5 g/day) is as effective as imipenem/cilastatin (2 g/day) for the treatment of moderately severe intra-abdominal infections.
Topics: Adult; APACHE; Cilastatin; Drug Therapy, Combination; Female; Humans; Imipenem; Male; Meropenem; Middle Aged; Peritonitis; Thienamycins | 1999 |
Imipenem versus netilmicin and vancomycin in the treatment of CAPD peritonitis.
Topics: Female; Humans; Imipenem; Male; Middle Aged; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis; Prospective Studies; Recurrence; Vancomycin | 1992 |
[Clinical evaluation of intramuscular imipenem/cilastatin sodium in surgical infections].
Topics: Adult; Aged; Cholangitis; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Female; Humans; Imipenem; Injections, Intramuscular; Male; Microbial Sensitivity Tests; Middle Aged; Peritonitis; Postoperative Complications | 1991 |
Results of a multicenter trial comparing imipenem/cilastatin to tobramycin/clindamycin for intra-abdominal infections.
Topics: Abscess; Adult; Aged; Anti-Bacterial Agents; Cilastatin; Cilastatin, Imipenem Drug Combination; Clindamycin; Drug Combinations; Drug Therapy, Combination; Female; Humans; Imipenem; Male; Middle Aged; Peritonitis; Prospective Studies; Severity of Illness Index; Tobramycin | 1990 |
Treatment of acute bacterial peritonitis: a trial of imipenem/cilastatin against ampicillin-metronidazole-gentamicin.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Ampicillin; Anti-Bacterial Agents; Bacterial Infections; Cilastatin; Cilastatin, Imipenem Drug Combination; Clinical Trials as Topic; Cyclopropanes; Drug Combinations; Drug Therapy, Combination; Female; Gentamicins; Humans; Imipenem; Male; Metronidazole; Middle Aged; Peritonitis; Random Allocation; Thienamycins | 1987 |
Treatment of intra-abdominal infections using imipenem/cilastatin.
Topics: Aged; Ampicillin; Anti-Bacterial Agents; Bacterial Infections; Cilastatin; Cilastatin, Imipenem Drug Combination; Clinical Trials as Topic; Drug Combinations; Female; Gentamicins; Humans; Imipenem; Male; Metronidazole; Peritonitis | 1987 |
Imipenem (N-F-thienamycin) versus netilmicin plus clindamycin. A controlled and randomized comparison in intra-abdominal infections.
Topics: Adolescent; Adult; Aged; Clindamycin; Clinical Trials as Topic; Drug Therapy, Combination; Female; Humans; Imipenem; Length of Stay; Male; Middle Aged; Netilmicin; Peritonitis; Postoperative Complications; Random Allocation; Reoperation; Surgical Wound Infection; Thienamycins | 1987 |
46 other study(ies) available for imipenem, anhydrous and Primary Peritonitis
Article | Year |
---|---|
Outcome and Adequacy of Empirical Antibiotherapy in Post-Operative Peritonitis: A Retrospective Study.
Topics: Adult; Aged; Aged, 80 and over; Aminoglycosides; Anastomotic Leak; Anti-Bacterial Agents; Ascitic Fluid; Clavulanic Acids; Cohort Studies; Culture Techniques; Digestive System Surgical Procedures; Disk Diffusion Antimicrobial Tests; Drug Resistance, Multiple, Bacterial; Female; Fluoroquinolones; Hospital Mortality; Humans; Imipenem; Male; Microbial Sensitivity Tests; Middle Aged; Multivariate Analysis; Peritonitis; Piperacillin, Tazobactam Drug Combination; Postoperative Complications; Prognosis; Retrospective Studies; Surgical Wound Infection; Ticarcillin; Treatment Outcome; Vancomycin | 2020 |
Expression of CTX-M-15 limits the efficacy of ceftolozane/tazobactam against Escherichia coli in a high-inoculum murine peritonitis model.
Topics: Animals; Anti-Bacterial Agents; Bacterial Load; beta-Lactamase Inhibitors; beta-Lactamases; Carbapenem-Resistant Enterobacteriaceae; Cephalosporins; Disease Models, Animal; Escherichia coli; Escherichia coli Infections; Imipenem; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Peritonitis; Tazobactam | 2020 |
The pathogen spectrum and resistance in patients with peritoneal dialysis-associated peritonitis: A single-center, observational clinical study
.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Antifungal Agents; Bacterial Infections; Cefazolin; Ceftriaxone; Drug Resistance, Bacterial; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Gram-Positive Cocci; Humans; Imipenem; Itraconazole; Male; Microbial Sensitivity Tests; Middle Aged; Mycoses; Peritoneal Dialysis; Peritonitis; Vancomycin; Voriconazole; Young Adult | 2019 |
Acute acalculous cholecystitis complicated with peritonitis caused by Lactobacillus plantarum.
Topics: Acalculous Cholecystitis; Anti-Bacterial Agents; Bile; Cholecystectomy; Cholecystitis, Acute; Diabetes Mellitus, Type 2; Gram-Positive Bacterial Infections; Humans; Imipenem; Lactobacillus plantarum; Male; Middle Aged; Peritonitis; Treatment Outcome | 2013 |
Risk factors associated with preoperative fecal carriage of extended-spectrum β-lactamase-producing Enterobacteriaceae in liver transplant recipients.
Topics: Adult; Amikacin; beta-Lactamases; beta-Lactams; Cefoxitin; Ciprofloxacin; Drug Resistance, Bacterial; End Stage Liver Disease; Enterobacter cloacae; Enterobacteriaceae; Enterobacteriaceae Infections; Escherichia coli; Escherichia coli Infections; Feces; Female; Humans; Imipenem; Klebsiella; Klebsiella Infections; Klebsiella pneumoniae; Liver Transplantation; Logistic Models; Male; Microbial Sensitivity Tests; Middle Aged; Multivariate Analysis; Penicillanic Acid; Peritonitis; Piperacillin; Piperacillin, Tazobactam Drug Combination; Preoperative Period; Risk Factors; Severity of Illness Index | 2014 |
[Clinical analysis for patients with continuous ambulatory peritoneal dialysis associated peritonitis].
Topics: Abdominal Pain; Anti-Bacterial Agents; Bacteria; Bacterial Infections; Candidiasis; Catheters; Diarrhea; Drug Resistance, Bacterial; Enterococcus faecalis; Escherichia coli; Fever; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Imipenem; Klebsiella pneumoniae; Microbial Sensitivity Tests; Mycoses; Penicillanic Acid; Peritoneal Dialysis; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis; Piperacillin; Piperacillin, Tazobactam Drug Combination; Recurrence; Retrospective Studies; Staphylococcus epidermidis; Staphylococcus haemolyticus; Vomiting | 2016 |
Clinical outcomes of spontaneous bacterial peritonitis due to extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella species: a retrospective matched case-control study.
Topics: Aged; Anti-Bacterial Agents; Ascites; beta-Lactam Resistance; beta-Lactamases; Case-Control Studies; Cephalosporins; Escherichia coli; Escherichia coli Infections; Female; Humans; Imipenem; Klebsiella; Klebsiella Infections; Liver Cirrhosis; Male; Middle Aged; Peritonitis; Retrospective Studies; Risk Factors; Treatment Failure | 2009 |
Comparative in vitro activity of Meropenem, Imipenem and Piperacillin/tazobactam against 1071 clinical isolates using 2 different methods: a French multicentre study.
Topics: Anti-Bacterial Agents; Bacteremia; France; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Imipenem; Meropenem; Microbial Sensitivity Tests; Penicillanic Acid; Peritonitis; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pneumonia, Bacterial; Thienamycins; Wound Infection | 2010 |
Kinetics of imipenem distribution into the peritoneal fluid of patients with severe peritonitis studied by microdialysis.
Topics: Aged; Anti-Bacterial Agents; Ascitic Fluid; Critical Illness; Female; Humans; Imipenem; Male; Microdialysis; Middle Aged; Models, Chemical; Peritonitis; Severity of Illness Index | 2010 |
In vitro and in vivo activities of linezolid alone and combined with vancomycin and imipenem against Staphylococcus aureus with reduced susceptibility to glycopeptides.
Topics: Acetamides; Animals; Ascitic Fluid; Bacteremia; Disease Models, Animal; Drug Resistance, Multiple, Bacterial; Drug Synergism; Drug Therapy, Combination; Glycopeptides; Imipenem; Linezolid; Methicillin Resistance; Methicillin-Resistant Staphylococcus aureus; Mice; Mice, Inbred C57BL; Microbial Sensitivity Tests; Oxazolidinones; Peritonitis; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 2010 |
Efficacy of fosfomycin and its combination with linezolid, vancomycin and imipenem in an experimental peritonitis model caused by a Staphylococcus aureus strain with reduced susceptibility to vancomycin.
Topics: Acetamides; Animals; Anti-Bacterial Agents; Ascitic Fluid; Bacteremia; Bacterial Load; Disease Models, Animal; Drug Therapy, Combination; Female; Fosfomycin; Humans; Imipenem; Linezolid; Mice; Mice, Inbred C57BL; Microbial Sensitivity Tests; Oxazolidinones; Peritonitis; Staphylococcal Infections; Treatment Outcome; Vancomycin | 2011 |
[Ochrobactrum anthropi and polymicrobial peritonitis in peritoneal dialysis: a resistance predictor].
Topics: Anti-Bacterial Agents; Antifungal Agents; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Female; Fluconazole; Glomerulonephritis, IGA; Gram-Negative Bacterial Infections; Humans; Imipenem; Middle Aged; Ochrobactrum anthropi; Peritoneal Dialysis; Peritonitis; Pseudomonas Infections | 2010 |
Local imipenem activity against Pseudomonas aeruginosa decreases in vivo in the presence of siliconized latex.
Topics: Animals; Anti-Bacterial Agents; Bacterial Load; Catheters; Disease Models, Animal; Drug Antagonism; Female; Foreign Bodies; Imipenem; Latex; Liver; Mice; Mice, Inbred C57BL; Peritonitis; Pseudomonas aeruginosa; Pseudomonas Infections; Silicon; Spleen; Treatment Outcome; Zinc | 2011 |
Peritonitis after gynecological and gastroscopic examinations in a peritoneal dialysis patient.
Topics: Amikacin; Anti-Bacterial Agents; Antibiotic Prophylaxis; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Enterococcus; Female; Gastroscopy; Gynecological Examination; Humans; Imipenem; Middle Aged; Peritoneal Dialysis; Peritonitis; Secondary Prevention; Treatment Outcome; Vancomycin | 2010 |
Broad-spectrum β-lactam antibiotics for treating experimental peritonitis in mice due to Klebsiella pneumoniae producing the carbapenemase OXA-48.
Topics: Animals; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Cefotaxime; Ceftazidime; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Ertapenem; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Lethal Dose 50; Mice; Penicillanic Acid; Peritonitis; Piperacillin; Piperacillin, Tazobactam Drug Combination; Plasmids; Survival Rate | 2012 |
Use of Carbapenems against clinical, nontyphoid Salmonella isolates: results from in vitro and in vivo animal studies.
Topics: Animals; beta-Lactams; Carbapenems; Cell Line; Doripenem; Ertapenem; Female; Imipenem; Meropenem; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Peritonitis; Salmonella; Thienamycins | 2012 |
Cationic peptides combined with betalactams reduce mortality from peritonitis in experimental rat model.
Topics: Amoxicillin-Potassium Clavulanate Combination; Animals; Anti-Bacterial Agents; Antimicrobial Cationic Peptides; Colistin; Colony Count, Microbial; Disease Models, Animal; Drug Therapy, Combination; Endotoxins; Exudates and Transudates; Imipenem; Male; Peritonitis; Proteins; Rats; Rats, Wistar; Sepsis; Tumor Necrosis Factor-alpha | 2002 |
Treatment of secondary peritonitis: is a less expensive broad-spectrum antibiotic as effective as a carbapenem?
Topics: Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Drug Costs; Drug Therapy, Combination; Female; Humans; Imipenem; Male; Microbial Sensitivity Tests; Middle Aged; Peritonitis; Practice Guidelines as Topic; Retrospective Studies; Treatment Outcome | 2003 |
Myoclonus associated with intraperitoneal imipenem.
Topics: Anti-Bacterial Agents; Ascitic Fluid; Child, Preschool; Enterobacter cloacae; Enterobacteriaceae Infections; Humans; Imipenem; Infusions, Parenteral; Kidney Failure, Chronic; Male; Medication Errors; Meropenem; Myoclonus; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis; Thienamycins; Tobramycin | 2004 |
Asaia bogorensis peritonitis identified by 16S ribosomal RNA sequence analysis in a patient receiving peritoneal dialysis.
Topics: Acetobacteraceae; Drug Therapy, Combination; Gram-Negative Bacterial Infections; Humans; Imipenem; Kidney Failure, Chronic; Peritoneal Dialysis; Peritonitis; Ribotyping; RNA, Bacterial; RNA, Ribosomal, 16S; Tobramycin | 2004 |
Pharmacodynamic modeling of beta-lactam antibiotics for the empiric treatment of secondary peritonitis: a report from the OPTAMA program.
Topics: Anti-Bacterial Agents; beta-Lactams; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Humans; Imipenem; Meropenem; Microbial Sensitivity Tests; Models, Biological; Monte Carlo Method; Penicillanic Acid; Peritonitis; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pseudomonas aeruginosa; Pseudomonas Infections; Thienamycins | 2005 |
Differential effect of imipenem treatment on wild-type and NK cell-deficient CD8 knockout mice during acute intra-abdominal injury.
Topics: Abdominal Injuries; Animals; Anti-Bacterial Agents; Bacterial Infections; CD8 Antigens; CD8-Positive T-Lymphocytes; Cecum; Cytokines; Female; Imipenem; Killer Cells, Natural; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Peritonitis; Treatment Outcome | 2006 |
Microdialysis study of imipenem distribution in the intraperitoneal fluid of rats with or without experimental peritonitis.
Topics: Animals; Anti-Bacterial Agents; Extracellular Fluid; Imipenem; Injections, Intravenous; Lung; Microdialysis; Peritonitis; Rats; Rats, Sprague-Dawley | 2006 |
Interaction of antimicrobial peptide temporin L with lipopolysaccharide in vitro and in experimental rat models of septic shock caused by gram-negative bacteria.
Topics: Animals; Anti-Infective Agents; Antimicrobial Cationic Peptides; beta-Lactams; Disease Models, Animal; Drug Therapy, Combination; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Imipenem; Lipopolysaccharides; Male; Microbial Sensitivity Tests; Peritonitis; Piperacillin; Proteins; Rats; Rats, Wistar; Shock, Septic | 2006 |
Successful use of sodium hypochlorite pack plus systemic and local antibiotic therapy for the treatment of pseudomonas infection of peritoneal dialysis catheter exit-site.
Topics: Anti-Bacterial Agents; Catheters, Indwelling; Cilastatin; Cross Infection; Disinfectants; Drug Therapy, Combination; Humans; Imipenem; Infection Control; Kidney Failure, Chronic; Peritoneal Dialysis; Peritonitis; Pseudomonas Infections; Sodium Hypochlorite | 2007 |
Spontaneous bacterial peritonitis in terminal renal failure.
Topics: Adult; Anti-Bacterial Agents; Ascites; Cefotaxime; Drug Therapy, Combination; Humans; Imipenem; Kidney Failure, Chronic; Male; Peritonitis; Renal Dialysis; Staphylococcal Infections; Staphylococcus epidermidis; Vancomycin | 2007 |
Effect of volume support, antibiotic therapy, and monoclonal antiendotoxin antibodies on mortality rate and blood concentrations of endothelin and other mediators in fulminant intra-abdominal sepsis in rats.
Topics: Animals; Antibodies, Monoclonal; Blood Volume; Cilastatin; Cilastatin, Imipenem Drug Combination; Combined Modality Therapy; Drug Combinations; Drug Evaluation, Preclinical; Drug Therapy, Combination; Endothelins; Fluid Therapy; Imipenem; Immunoglobulins; Male; Peritonitis; Prospective Studies; Random Allocation; Rats; Rats, Wistar; Sepsis; Time Factors | 1995 |
Imipenem/cilastatin in the treatment of CAPD peritonitis.
Topics: Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Drug Therapy, Combination; Humans; Imipenem; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis | 1995 |
Investigation of the potential role of Enterococcus faecalis in the pathophysiology of experimental peritonitis.
Topics: Abscess; Amoxicillin; Animals; Anti-Bacterial Agents; Bacteremia; Bacteroides fragilis; Bacteroides Infections; Body Weight; Disease Models, Animal; Drug Synergism; Enterococcus faecalis; Escherichia coli; Escherichia coli Infections; Gentamicins; Gram-Positive Bacterial Infections; Imipenem; Male; Microbial Sensitivity Tests; Ornidazole; Pefloxacin; Peritoneum; Peritonitis; Rats; Rats, Sprague-Dawley; Specific Pathogen-Free Organisms | 1994 |
[Contribution of imipenem-cilastatin in the treatment of peritonitis: a comparative economical analysis in the case of France].
Topics: Cilastatin; Drug Therapy, Combination; France; Humans; Imipenem; Peritonitis | 1993 |
[Primary peritonitis caused by Streptococcus pneumoniae].
Topics: Abdominal Pain; Adult; Amikacin; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Bacteremia; Cilastatin; Diarrhea; Drug Therapy, Combination; Female; Fever; Humans; Imipenem; Laparotomy; Penicillins; Peritonitis; Pneumococcal Infections; Protease Inhibitors; Puerperal Infection; Thienamycins; Treatment Outcome; Vagina | 1997 |
Neurological complication during imipenem/cilastatin therapy in uraemic patients.
Topics: Aged; Aged, 80 and over; Cilastatin; Confusion; Female; Humans; Imipenem; Male; Middle Aged; Nervous System; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis; Protease Inhibitors; Seizures; Thienamycins; Tremor; Uremia | 1998 |
Neurotoxicity due to imipenem/cilastatin in patients on continuous ambulatory peritoneal dialysis.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Infections; Cilastatin; Humans; Imipenem; Kidney Failure, Chronic; Male; Middle Aged; Myoclonus; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis; Protease Inhibitors; Pruritus; Thienamycins | 1999 |
Multiple roles for IL-12 in a model of acute septic peritonitis.
Topics: Acute Disease; Animals; Cecal Diseases; Cilastatin; Cilastatin, Imipenem Drug Combination; Disease Models, Animal; Drug Combinations; Drug Therapy, Combination; Female; Fibrosis; Imipenem; Immune Sera; Immunization, Passive; Interferon-gamma; Interleukin-10; Interleukin-12; Intestinal Perforation; Ligation; Mice; Peritoneum; Peritonitis; Sepsis; Wound Healing | 1999 |
Local treatment of generalised peritonitis in rats; effects on bacteria, endotoxin and mortality.
Topics: Abdominal Abscess; Animals; Anti-Infective Agents, Local; Cilastatin; Debridement; Drug Combinations; Endotoxins; Imipenem; Instillation, Drug; Male; Peritonitis; Protease Inhibitors; Rats; Rats, Wistar; Taurine; Therapeutic Irrigation; Thiadiazines; Thienamycins | 1999 |
[Experience in the use of imipenem/cilastatin (thienam) in a surgical clinic].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antibiotic Prophylaxis; Cilastatin; Cilastatin, Imipenem Drug Combination; Diabetic Foot; Drug Combinations; Female; Humans; Imipenem; Male; Middle Aged; Pancreatitis, Acute Necrotizing; Peritonitis; Postoperative Care; Protease Inhibitors; Suppuration; Thienamycins | 2000 |
Inhibition of nitric oxide synthesis improves survival in a murine peritonitis model of sepsis that is not cured by antibiotics alone.
Topics: Amino Acid Oxidoreductases; Animals; Arginine; Cilastatin; Cilastatin, Imipenem Drug Combination; Disease Models, Animal; Drug Combinations; Drug Therapy, Combination; Escherichia coli Infections; Imipenem; Male; Mice; Nitric Oxide Synthase; omega-N-Methylarginine; Peritonitis | 1992 |
Pharmacokinetics of imipenem/cilastatin sodium in children with peritonitis.
Topics: Child; Child, Preschool; Cilastatin; Drug Therapy, Combination; Humans; Imipenem; Infusions, Intravenous; Peritonitis | 1992 |
[Resistance to antibiotic treatment produced in a model of experimental Pseudomonas aeruginosa peritonitis].
Topics: Amikacin; Animals; Ceftazidime; Ciprofloxacin; Disease Models, Animal; Drug Resistance, Microbial; Drug Therapy, Combination; Imipenem; Mice; Peritonitis; Pseudomonas aeruginosa; Pseudomonas Infections | 1992 |
Response of Weeksella virosa peritonitis to imipenem/cilastin.
Topics: Adult; Anti-Bacterial Agents; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Female; Gram-Negative Bacterial Infections; Humans; Imipenem; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis | 1991 |
In-vitro activity of imipenem, in comparison with cefuroxime and ciprofloxacin, against coagulase-negative staphylococci in broth and peritoneal dialysis fluid.
Topics: Cefuroxime; Ciprofloxacin; Dialysis Solutions; Drug Resistance, Microbial; Humans; Imipenem; Microbial Sensitivity Tests; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis; Staphylococcus | 1992 |
Comparison of the efficacy of three different treatments with imipenem versus the classical clindamycin plus tobramycin in experimental peritonitis.
Topics: Abscess; Animals; Ascitic Fluid; Cilastatin; Clindamycin; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Imipenem; Peritonitis; Rats; Rats, Inbred Strains; Tobramycin | 1991 |
Campylobacter jejuni peritonitis during chronic ambulatory peritoneal dialysis (CAPD).
Topics: Campylobacter Infections; Campylobacter jejuni; Female; Humans; Imipenem; Middle Aged; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis; Streptokinase | 1990 |
[Study of the intraperitoneal penetration of imipenem/cilastatin in acute peritonitis with perforation].
Topics: Acute Disease; Aged; Cilastatin; Drug Therapy, Combination; Female; Humans; Imipenem; Intestinal Perforation; Male; Peritoneal Cavity; Peritonitis | 1990 |
[Experience with imipenem/cilastatin sodium in the field of obstetrics and gynecology].
Topics: Abscess; Adult; Cilastatin; Cyclopropanes; Drug Combinations; Female; Genitalia, Female; Humans; Imipenem; Middle Aged; Pelvis; Peritonitis; Salpingitis; Thienamycins; Vulvar Diseases | 1986 |
[Calculated initial chemotherapy in mechanically-ventilated postoperative patients with peritonitis, sepsis and pneumonia].
Topics: Adult; Bacterial Infections; Cilastatin; Cilastatin, Imipenem Drug Combination; Cyclopropanes; Drug Combinations; Female; Humans; Imipenem; Male; Middle Aged; Peritonitis; Pneumonia; Postoperative Complications; Respiration, Artificial; Retrospective Studies; Sepsis; Thienamycins | 1986 |